IMRX insider transaction filings
Immuneering Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen IMRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Gengos Andrew — Chief Financial Officer | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Zeskind Benjamin J. — PRESIDENT AND CEO, Director | Purchase (P): 2,400 @ $4.56 | EDGAR |
| 2026-06-16 | 4 | Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER | Purchase (P): 6,035 @ $4.15 | EDGAR |
| 2026-06-11 | 4 | Feinberg Peter — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | KEATING LAURIE — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | HAUSMAN DIANA — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Schall Thomas J. — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | CARPENTER ROBERT J — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Neufeld Leah R — CHIEF PEOPLE OFFICER | Grant/award (A): 3,628 @ $4.29 | EDGAR |
| 2026-02-05 | 4 | Bookman Michael — CHIEF LEGAL OFFICER, SECRETARY | Grant/award (A): 176,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Brakewood Harold Eugene — Chief Business Officer | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 344,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Morales Mallory — SVP Finance, CAO | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Neufeld Leah R — CHIEF PEOPLE OFFICER | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Zeskind Benjamin J. — PRESIDENT AND CEO, Director | Grant/award (A): 688,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Matushansky Igor — Chief Medical Officer | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Brakewood Harold Eugene — Chief Business Officer | Purchase (P): 5,250 @ $4.76 | EDGAR |
| 2026-01-20 | 4 | Schall Thomas J. — Director | Purchase (P): 21,645 @ $4.67 | EDGAR |
| 2026-01-16 | 4 | Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER | Purchase (P): 2,298 @ $4.57 | EDGAR |
| 2026-01-15 | 4 | Neufeld Leah R — CHIEF PEOPLE OFFICER | Purchase (P): 2,626 @ $4.15 | EDGAR |
| 2026-01-14 | 4 | Feinberg Peter — Director | Purchase (P): 20,000 @ $4.35 | EDGAR |
| 2026-01-02 | 4 | Feinberg Peter — Director | Grant/award (A): 7,888 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | KEATING LAURIE — Director | Grant/award (A): 7,888 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Feinberg Peter — Director | Purchase (P): 7,500 @ $6.67 | EDGAR |
| 2025-10-02 | 4 | Morales Mallory — Chief Accounting Officer | Purchase (P): 300 @ $6.39 | EDGAR |
| 2025-10-02 | 4 | Neufeld Leah R — CHIEF PEOPLE OFFICER | Purchase (P): 800 @ $6.38 | EDGAR |
| 2025-10-02 | 4 | Bookman Michael — CHIEF LEGAL OFFICER, SECRETARY | Purchase (P): 1,020 @ $6.83 | EDGAR |
| 2025-10-01 | 4 | Feinberg Peter — Director | Purchase (P): 7,500 @ $7.03 | EDGAR |
| 2025-09-30 | 4 | Feinberg Peter — Director | Purchase (P): 5,000 @ $7.18 | EDGAR |
| 2025-09-17 | 4 | Neufeld Leah R — CHIEF PEOPLE OFFICER | Grant/award (A): 11,815 @ $1.43 | EDGAR |
| 2025-09-17 | 4 | Morales Mallory — Chief Accounting Officer | Grant/award (A): 14,497 @ $1.43 | EDGAR |
| 2025-09-17 | 4 | Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 14,880 @ $1.43 | EDGAR |
| 2025-07-07 | 4 | Neufeld Leah R — CHIEF PEOPLE OFFICER | Purchase (P): 700 @ $3.57 | EDGAR |
| 2025-07-07 | 4 | HAUSMAN DIANA — Director | Purchase (P): 2,500 @ $3.60 · Purchase (P): 3,000 @ $3.62 | EDGAR |
| 2025-07-03 | 4 | Zeskind Benjamin J. — PRESIDENT AND CEO, Director, 10% owner | Purchase (P): 2,985 @ $3.38 · Purchase (P): 7,015 @ $3.53 | EDGAR |
| 2025-06-30 | 4 | Schall Thomas J. — Director | Purchase (P): 9,500 @ $3.66 | EDGAR |
| 2025-06-24 | 4 | Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER | Purchase (P): 7,415 @ $2.70 · Purchase (P): 6,007 @ $2.43 | EDGAR |
| 2025-06-24 | 4 | Brakewood Harold Eugene — Chief Business Officer | Purchase (P): 1,900 @ $2.53 | EDGAR |
| 2025-06-23 | 4 | Feinberg Peter — Director | Purchase (P): 25,000 @ $2.53 | EDGAR |
| 2025-06-20 | 4 | Zeskind Benjamin J. — PRESIDENT AND CEO, Director, 10% owner | Purchase (P): 21,000 @ $2.39 | EDGAR |
| 2025-06-18 | 4 | Schall Thomas J. — Director | Purchase (P): 40,485 @ $2.21 | EDGAR |
| 2025-06-16 | 4 | Feinberg Peter — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | KEATING LAURIE — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | HAUSMAN DIANA — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Schall Thomas J. — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | BERMAN ANN E — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | CARPENTER ROBERT J — Director | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Matushansky Igor — Chief Medical Officer | Grant/award (A): 118,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Morales Mallory — Chief Accounting Officer | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Neufeld Leah R — CHIEF PEOPLE OFFICER | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Immuneering Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IMRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →